Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dyne Therapeutics, Inc.

10.99
+0.21001.95%
Volume:587.67K
Turnover:6.46M
Market Cap:1.24B
PE:-3.26
High:11.13
Open:10.93
Low:10.74
Close:10.78
Loading ...

Dyne Therapeutics Gets EU Orphan Drug Status for Duchenne Treatment

MT Newswires Live
·
Yesterday

BRIEF-Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation For DYNE-251 In Duchenne Muscular Dystrophy

Reuters
·
Yesterday

Dyne Therapeutics Receives European Medicines Agency (Ema) Orphan Drug Designation for Dyne-251 in Duchenne Muscular Dystrophy

THOMSON REUTERS
·
Yesterday

Dyne Therapeutics appoints Ranade as CBO, Batra as CSO

TIPRANKS
·
15 Apr

Press Release: Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments

Dow Jones
·
15 Apr

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
15 Apr

Insider Purchases Worth US$1.06m See Losses As Dyne Therapeutics Market Value Drops To US$770m

Simply Wall St.
·
10 Apr

Dyne Therapeutics Inc : RBC Cuts Target Price to $36 From $41

THOMSON REUTERS
·
03 Apr

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks
·
01 Apr

Dyne Therapeutics Is Maintained at Neutral by JP Morgan

Dow Jones
·
22 Mar

Sector Update: Health Care Stocks Steady Premarket Friday

MT Newswires Live
·
21 Mar

U.S. RESEARCH ROUNDUP-Darden Restaurants, Nike, Optinose

Reuters
·
21 Mar

Dyne Therapeutics Inc : JP Morgan Cuts Target Price to $17 From $18

THOMSON REUTERS
·
21 Mar

Dyne Therapeutics Names Erick Lucera as CFO

MT Newswires Live
·
21 Mar

Dyne Therapeutics Names Editas Medicine's Lucera as CFO

Dow Jones
·
21 Mar

BRIEF-Dyne Therapeutics Announces Appointment of Erick J. Lucera As Chief Financial Officer

Reuters
·
21 Mar

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) to Newly Appointed Chief Financial Officer

THOMSON REUTERS
·
21 Mar

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Financial Officer

GlobeNewswire
·
21 Mar

Dyne Therapeutics Announces Appointment of Erick J. Lucera as Chief Financial Officer

THOMSON REUTERS
·
21 Mar

Press Release: Dyne Therapeutics Announces Appointment of Erick J. Lucera as Chief Financial Officer

Dow Jones
·
21 Mar